AQP4 and neuromyelitis optica: Quantification analysis revealed that signal intensity of AQP4 and GFAP double-positive area was increased in NMO rats receiving anti-RGMa mAb treatment compared with Control-IgG-treated NMO rats (Fig. 2J,K).